loadpatents
name:-0.023845911026001
name:-0.011829137802124
name:-0.0026299953460693
Luqman; Mohammad Patent Filings

Luqman; Mohammad

Patent Applications and Registrations

Patent applications and USPTO patent grants for Luqman; Mohammad.The latest application filed is for "message recommendation system".

Company Profile
2.12.20
  • Luqman; Mohammad - Redmond WA
  • Luqman; Mohammad - Danville CA
  • Luqman; Mohammad - Emeryville CA
  • Luqman; Mohammad - Acton MA
  • Luqman; Mohammad - Waltham MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Message recommendation system
Grant 11,184,301 - Menon , et al. November 23, 2
2021-11-23
Multiple-entity-based Recommendation System
App 20210049442 - Menon; Lekshmi ;   et al.
2021-02-18
Message Recommendation System
App 20210051121 - Menon; Lekshmi ;   et al.
2021-02-18
Prlr-specific Antibody And Uses Thereof
App 20150175705 - Damiano; Jason ;   et al.
2015-06-25
PRLR-specific antibody and uses thereof
Grant 9,005,614 - Damiano , et al. April 14, 2
2015-04-14
Uses Of Anti-cd40 Antibodies
App 20150086991 - Aukerman; Sharon Lea ;   et al.
2015-03-26
Treatment of cancer or pre-malignant conditions using anti-CD40 antibodies
Grant 8,926,979 - Aukerman , et al. January 6, 2
2015-01-06
Antagonist Anti-cd40 Monoclonal Antibodies And Methods For Their Use
App 20140205602 - Long; Li ;   et al.
2014-07-24
Antagonist anti-CD40 monoclonal antibodies and methods for their use
Grant 8,637,032 - Long , et al. January 28, 2
2014-01-28
Methods For Diagnosis And Treatment Of Proliferative Disorders Mediated By Cd40 Signaling
App 20130230528 - Aukerman; Sharon Lea ;   et al.
2013-09-05
Antagonist Anti-cd40 Monoclonal Antibodies And Methods For Their Use
App 20130011405 - Long; Li ;   et al.
2013-01-10
Methods of monitoring the efficacy of anti-CD40 antibodies in treating a subject for a CD40-expressing cancer
Grant 8,337,851 - Aukerman , et al. December 25, 2
2012-12-25
Methods of monitoring the efficacy of anti-CD40 antibodies in treating a subject having an inflammatory or autoimmune disease
Grant 8,333,970 - Aukerman , et al. December 18, 2
2012-12-18
Antagonist anti-CD40 antibodies
Grant 8,277,810 - Long , et al. October 2, 2
2012-10-02
PRLR-Specific Antibody and Uses Thereof
App 20110150760 - DAMIANO; JASON ;   et al.
2011-06-23
PRLR-specific antibody and uses thereof
Grant 7,867,493 - Damiano , et al. January 11, 2
2011-01-11
Uses Of Anti-cd40 Antibodies
App 20110002934 - Luqman; Mohammad ;   et al.
2011-01-06
Uses Of Anti-cd40 Antibodies
App 20090202531 - Aukerman; Sharon Lea ;   et al.
2009-08-13
Uses Of Anti-cd40 Antibodies
App 20090117111 - Aukerman; Sharon Lea ;   et al.
2009-05-07
Methods For Diagnosis And Treatment Of Proliferative Disorders Mediated By Cd40 Signaling
App 20090041773 - Aukerman; Sharon Lea ;   et al.
2009-02-12
PRLR-Specific Antibody and Uses Thereof
App 20080292620 - Damiano; Jason ;   et al.
2008-11-27
Methods for Diagnosis and Treatment of Diseases Having an Autoimmune and/or Inflammatory Component
App 20080274118 - Aukerman; Sharon Lea ;   et al.
2008-11-06
Antagonist Anti-cd40 Monoclonal Antibodies And Methods For Their Use
App 20080254026 - Long; Li ;   et al.
2008-10-16
Antagonist Anti-Cd40 Monoclonal Antibodies and Methods for Their Use
App 20080057070 - Long; Li ;   et al.
2008-03-06
Antagonist Anti-Cd40 Monoclonal Antibodies and Methods for Their Use
App 20070292439 - Luqman; Mohammad
2007-12-20
Use of Antagonist Anti-Cd40 Monoclonal Antibodies for Treatment of Multiple Myeloma
App 20070218060 - Long; Li ;   et al.
2007-09-20
Use of antagonist anti-cd40 antibodies for treatment of chronic lymphocytic leukemia
App 20070110754 - Long; Li ;   et al.
2007-05-17
Methods of therapy for b cell-related cancers
App 20070098718 - Long; Li ;   et al.
2007-05-03
T cell epitopes of ryegrass pollen allergen
Grant 7,112,333 - Griffith , et al. September 26, 2
2006-09-26
T cell epitopes of ryegrass pollen allergen
Grant 5,710,126 - Griffith , et al. January 20, 1
1998-01-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed